Notably, the proportion of CD16+CD56+-positive cells in children with MCNS relapse was much higher than that in children without relapse (21.2% [7.2%] vs 3.8% [5.4%]; P = 0.042). The gene discussed is NCAM1; the disease is lipoid nephrosis.